SELZENTRY (Physicians Total Care, Inc.)


Welcome to the PulseAid listing for the SELZENTRY drug offered from Physicians Total Care, Inc.. This CCR5 Co-receptor Antagonist [EPC],Chemokine Co-receptor 5 Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Physicians Total Care, Inc.
NON-PROPRIETARY NAME: Maraviroc
SUBSTANCE NAME: MARAVIROC
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: CCR5 Co-receptor Antagonist [EPC],Chemokine Co-receptor 5 Antagonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2007-12-19
END MARKETING DATE: 0000-00-00


SELZENTRY HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSELZENTRY from Physicians Total Care, Inc.
LABELER NAME: Physicians Total Care, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 300(mg/1)
START MARKETING DATE: 2007-12-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54868-5809_0ba46c78-f90c-4c2b-9712-3a6cae5f0a44
PRODUCT NDC: 54868-5809
APPLICATION NUMBER: NDA022128

Other MARAVIROC Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Pfizer Laboratories Div Pfizer IncSELZENTRY
Physicians Total Care, Inc.SELZENTRY
ViiV Healthcare CompanySELZENTRY